What was recalled
The U.S. Food and Drug Administration has issued a recall for specific batches of Levothyroxine Sodium Tablets, USP, manufactured by Accord Healthcare, Inc. This is not a broad recall affecting every bottle of this medication on the market; rather, it targets precise inventory identified by unique National Drug Codes (NDC), lot numbers, and expiration dates. The affected product is the 100 mcg (0.1 mg) strength of Levothyroxine Sodium Tablets, which are prescription-only medications used to treat thyroid hormone deficiency. Understanding exactly which bottles are involved is critical because taking the wrong version or an expired batch can lead to serious health complications, while other batches from the same manufacturer remain safe for use.
The recall specifically impacts two packaging configurations distributed nationwide within the United States. The first configuration consists of 90-count bottles identified by NDC 16729-451-15. The second configuration includes 1,000-count bottles, which are typically intended for institutional or pharmacy stock rather than individual consumers, identified by NDC 16729-451-17. Accord Healthcare, Inc., based in Raleigh, North Carolina, is the company that marketed these tablets, while the actual manufacturing was carried out by Intas Pharmaceuticals Limited in Selaqui, Dehradun, India. This distinction is important for tracing the supply chain and understanding the scope of the distribution pattern.
To determine if you are holding a recalled item, you must look closely at your bottle’s label for specific lot numbers and expiration dates. For the 90-count bottles (NDC 16729-451-15), only Lot # D2402186 with an expiration date of September 30, 2026, is included in this recall. For the larger 1,000-count bottles (NDC 16729-451-17), the recall covers multiple lots: Lot # D2402019 expiring August 31, 2026; Lot # D2402094 expiring September 30, 2026; and Lots D2500022, D2500023, and D2500021, all of which expire on December 31, 2026. If your medication does not match these exact NDCs, lot numbers, and expiration dates, it is not part of this specific recall action. The recall was officially announced on August 6, 2026, marking the date when Accord Healthcare initiated the removal of these products from the market to protect public health.
The hazard, explained
In this specific recall, the core issue is that Levothyroxine Sodium Tablets are "subpotent." In plain language, this means the medication does not contain the full amount of active ingredient it claims to have on its label. While the bottle says you are taking 100 mcg (or 0.1 mg) of levothyroxine sodium, the actual chemical content in these specific lots is lower than that stated dose. This is not a case of contamination with a foreign substance or a bacterial issue; rather, it is a precision failure in manufacturing where the drug is essentially "weaker" than intended.
To understand why this matters, it helps to look at what levothyroxine actually does in your body. Levothyroxine is a synthetic version of thyroxine (T4), a hormone naturally produced by your thyroid gland. This hormone is the master regulator of your metabolism. It controls how quickly your body uses energy, makes proteins, and regulates your sensitivity to other hormones. For people with hypothyroidism—a condition where the thyroid gland is underactive—taking levothyroxine is not optional; it is a daily necessity to keep their metabolic systems running normally.
The danger here lies in the narrow therapeutic window of this drug. Unlike some medications where taking slightly less than the prescribed dose might just mean "it’s not working as well," levothyroxine requires precise dosing to maintain homeostasis. When the drug is subpotent, your body effectively goes into a state of untreated or undertreated hypothyroidism. Even a small drop in hormone levels can trigger a cascade of physiological symptoms because the thyroid hormone receptors in your cells are not being adequately stimulated.
Physically, what happens next is that your metabolic rate slows down significantly. You may experience profound fatigue, feeling tired even after adequate sleep. Your body temperature regulation may falter, leading to unusual sensitivity to cold temperatures. Other common effects include unexplained weight gain or difficulty losing weight, dry skin and hair, constipation, and a slower heart rate (bradycardia). In more severe cases, prolonged exposure to subpotent doses can lead to elevated levels of cholesterol in the blood and, in extreme untreated scenarios, a dangerous condition known as myxedema coma, which is a life-threatening drop in metabolic activity.
Because the manufacturing process failed to deliver the correct potency, patients who rely on this medication for thyroid hormone replacement are inadvertently receiving inadequate therapy. This is particularly critical because levothyroxine has a long half-life (about 7 days), meaning it takes time for levels to build up or drop. A subpotent dose creates a slow, creeping deficiency that can be difficult to detect immediately without blood tests, but the physical toll accumulates daily. The FDA’s Class II classification indicates that while use of this product is not likely to cause serious adverse health consequences in most people, it could cause temporary medical problems or require correction before permanent damage occurs, which is why identifying and stopping use of these specific lots is important for managing your long-term health.
Who is most at risk
When we talk about who is "at risk" in a recall of Levothyroxine Sodium, we are looking at two distinct groups: those who currently possess the specific recalled bottles and those whose health relies on precise thyroid hormone levels. First and foremost, anyone who has purchased Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) from Accord Healthcare, Inc., is directly affected. This includes patients in the United States who received these medications through their pharmacies or healthcare providers. The specific risk here is tied to the distribution pattern, which was nationwide, meaning there is no geographic safety net. If you were prescribed this medication by a doctor who sources inventory broadly, you may have one of the affected lots in your medicine cabinet right now.
For the general population, taking an extra dose of thyroid medication or missing a dose occasionally might cause temporary discomfort, such as jitteriness, heart palpitations, or anxiety. However, for individuals managing hypothyroidism, consistency is not just a matter of comfort—it is a matter of physiological stability. Levothyroxine is used to replace or supplement the natural thyroxine hormone produced by the thyroid gland. When this hormone is deficient, the body’s metabolic processes slow down. Therefore, the people most vulnerable to the consequences of a subpotent drug are those who have little room for error in their treatment plan.
The elderly population faces heightened risks when taking subpotent thyroid medications. Older adults often have multiple comorbidities and may be more sensitive to fluctuations in hormone levels. If the medication does not contain the full labeled amount of active ingredient, the body remains under-treated. This can lead to worsening symptoms of hypothyroidism, such as extreme fatigue, cold intolerance, weight gain, and depression. In severe cases, untreated hypothyroidism in older adults can contribute to heart problems, including elevated cholesterol levels and even myxedema coma, a rare but life-threatening condition where bodily functions slow to a dangerous halt.
Pregnant individuals are another critical group at risk. Thyroid hormone is essential for fetal brain development, particularly during the first trimester. Even slight deviations in maternal thyroid hormone levels can impact cognitive outcomes for the developing baby. A subpotent drug could mean that a pregnant person’s levels drop below the target range required for healthy fetal growth, introducing risks that extend far beyond their own physical health. Additionally, patients with pre-existing heart conditions are at risk because hypothyroidism can exacerbate cardiovascular strain. If the medication is not working as intended, the heart must work harder to pump blood through a slower metabolic system, potentially leading to arrhythmias or other cardiac events. It is crucial for these vulnerable groups to verify their medication status immediately and consult their healthcare provider before making any changes to their dosage.
How to tell if you have the recalled item
When dealing with a medication recall, especially one involving thyroid hormone replacement like Levothyroxine Sodium, precision is your best friend. Because this product looks like thousands of other generic thyroid medications on pharmacy shelves, you cannot rely on the bottle’s color or general shape to confirm safety. Instead, you must perform a careful, line-by-line audit of the information printed directly on your medication packaging. The most critical piece of data for this specific recall is the National Drug Code (NDC), a unique 10-digit identifier that acts as the product’s fingerprint. For this recall, Accord Healthcare, Inc. has identified two specific NDCs that are affected: 16729-451-15 and 16729-451-17. If your bottle does not display one of these exact codes, it is not part of this specific recall, regardless of the brand name or dosage strength.
The NDC is typically located on the side panel of the prescription bottle label. It will appear as a sequence of numbers separated by hyphens. In this case, you are looking for the prefix "16729," which identifies the manufacturer, Accord Healthcare, followed by the specific product code "451," and finally the package size code, either "15" for the 90-count bottle or "17" for the 1000-count bottle. It is important to note that this recall applies strictly to Levothyroxine Sodium Tablets, USP, in the 100 mcg (0.1 mg) strength. If you have a different dosage, such as 50 mcg or 75 mcg, it is not included in this specific alert, even if it shares the same NDC prefix.
Once you have confirmed the correct NDC and dosage, your next step is to check the lot number and expiration date. These details are crucial because the subpotent drug hazard is limited to specific production runs. For the 90-count bottles (NDC 16729-451-15), you must look for Lot Number D2402186 with an expiration date of 09/30/2026. For the larger 1000-count bottles (NDC 16729-451-17), the recall covers multiple lots: D2402019 (Exp. 08/31/2026), D2402094 (Exp. 09/30/2026), and the batch D2500022, D2500023, or D2500021 (all Exp. 12/31/2026). These numbers are usually printed on the back of the label near the barcode or in a designated "Lot/Exp" box. If your bottle has a different lot number, even if it is the same NDC and dosage, it is not part of this recall.
If you have an older prescription that was filled some time ago, check the original pharmacy receipt or your online patient portal history. Sometimes the physical label on the bottle can become worn or torn, obscuring the lot number. In such cases, your pharmacist can look up the dispensed medication using your date of service and confirm whether it matches the recalled lots. Remember, this recall is nationwide, so it does not matter which state you purchased the medication in; if the NDC and lot numbers match, it is affected. Do not guess based on memory or general appearance. Take the time to verify these specific identifiers to ensure your health remains stable and secure.
What to do — step by step
If you are reading this because you suspect you have one of the recalled Levothyroxine Sodium Tablets from Accord Healthcare, Inc., it is completely understandable to feel a bit overwhelmed. Medication recalls can be stressful, especially when they involve daily health management like thyroid treatment. However, please take a deep breath and follow these steps calmly. The most important thing right now is that you do not panic, but you also must not simply ignore the issue. Because the FDA has classified this as a Class II recall due to the drug being subpotent—meaning it may not contain the full amount of active ingredient needed—it requires careful attention to your health and proper disposal procedures. First and foremost, you must stop taking the medication immediately. Do not take another dose from the affected bottles. Levothyroxine is a hormone replacement therapy, and consistency in dosage is critical for maintaining stable thyroid levels. Taking a subpotent version could lead to your thyroid-stimulating hormone (TSH) levels rising, which might cause symptoms like fatigue, weight gain, or cold intolerance to return. However, do not just stop cold turkey without a plan, as sudden changes can impact how you feel. You need to contact your healthcare provider or pharmacist right away to discuss a transition plan. They may advise you to start a new prescription from a different manufacturer or lot number immediately to ensure there is no gap in your treatment. Next, verify exactly which bottles you have. Look at the label on the packaging for the National Drug Code (NDC) 16729-451-15 for the 90-count bottles or NDC 16729-451-17 for the 1000-count bottles. Then, check the lot number and expiration date on the box. The recalled lots are D2402186 (expires 09/30/2026), D2402019 (expires 08/31/2026), D2402094 (expires 09/30/2026), and the group D2500022, D2500023, and D2500021 (all expire 12/31/2026). If your bottle matches these details, it is part of the recall. Regarding the remedy, the official FDA notice does not currently state a specific return address, refund process, or replacement program provided by Accord Healthcare for this specific recall event. This means you should not expect a prepaid shipping label in the mail unless further updates are issued. Instead, your primary action items are to secure an alternative source of medication through your pharmacy and to dispose of the recalled product safely. Do not flush these tablets down the toilet or throw them in the household trash where they could be accidentally ingested by children or pets. Check with your local pharmacy or waste management authority about their drug take-back programs, which are the safest way to dispose of unused medications. Finally, keep your prescription bottle and receipt as proof of purchase in case you need to dispute charges with your insurance company or pharmacy if they refuse to cover the replacement medication due to the recall. While the manufacturer has not outlined a direct financial remedy here, pharmacies often have policies for replacing recalled items at no cost to the customer. Stay in close contact with your doctor to monitor your thyroid levels via blood work in the coming weeks to ensure your treatment remains effective during this transition.Your refund, repair, or replacement options
When a medication recall occurs, the most immediate concern for many consumers is the logistical process of returning the product and understanding what financial recourse is available. In this specific instance involving Accord Healthcare, Inc., the official FDA documentation indicates that a specific remedy—such as a direct refund, store credit, or replacement shipment—has not been explicitly stated in the public recall notice. This absence of detailed remedial instructions in the initial report can be confusing, but it does not mean you are without options. It simply means that the standard pathway for resolution is to initiate contact with the manufacturer directly to establish your individual case.
The first and most critical step you must take is to reach out to Accord Healthcare, Inc., the company responsible for this recall. As noted in the distribution pattern, this product was manufactured for Accord Healthcare, based in Raleigh, North Carolina. Because the recall affects Levothyroxine Sodium Tablets distributed nationwide, the company’s customer service or regulatory affairs department is the primary entity equipped to handle returns and inquiries regarding compensation. You should locate the contact information provided on your original packaging, your pharmacy receipt, or by searching the official Accord Healthcare website for their current customer support or recall-specific hotline. When you call or email them, have your lot number ready, as this is the key identifier that proves your specific bottle is part of the affected batch.
It is important to understand why the remedy might not be listed publicly right away. Often, in Class II recalls involving subpotent drugs, the company works with distributors and pharmacies to manage the return logistics rather than issuing blanket refunds to every consumer immediately. The "remedy" may involve a credit issued to your pharmacy account, which they can then apply to your next prescription fill, or a direct reimbursement process that requires you to submit proof of purchase. Do not assume that no remedy exists because it is not printed in the news alert; rather, view the lack of public detail as a signal to engage directly with the seller or manufacturer.
If you purchased these tablets from a pharmacy, your pharmacist is an invaluable ally in this process. They often have direct lines to the wholesaler and can facilitate the return of the product on your behalf. Ask them if they are processing returns for this specific lot number and if they can apply any credit or refund to your account balance. If you bought the product online, check the retailer’s return policy for recalled items, as many major e-commerce platforms have expedited processes for hazardous or defective goods. Keep all your receipts and the physical bottle until you have confirmed with Accord Healthcare or your pharmacy exactly how they intend to resolve the situation. Your goal is to ensure that you are not financially penalized for a defect that was entirely outside your control.
While waiting for instructions on financial restitution, please do not attempt to sell or give away any remaining tablets from the affected lots. The integrity of the recall depends on the complete removal of these products from the market and from private homes. By cooperating fully with the manufacturer’s return process, you help ensure that no one else is exposed to the risk of consuming a subpotent drug. Stay patient but persistent in your communications; if you do not receive a clear explanation of the refund or replacement process within a few days, follow up until you have a written confirmation of how your financial loss will be addressed.